Bones & Joints
Bones & Joints
Collaborative, years-long patient studies analyse the heterogeneity of tumours
Collaboration is the way forward as multiple teams work together on new studies of cancer. Some tumours have many different parts – can identifying which tumours are the most variable give us some prognostic information to guide treatment?
Transforming the lives of young adults with cancer by getting them moving again
Every day in the UK, 34 young adults are told they have cancer. Trekstock are working hard to meet the unique needs of this unsupported group.
Targeted therapy aims to outwit evolving tumours
Studies show how cancer cells can evolve so as to resist and evade treatment. Now trials aim to use this new knowledge to help fight back.
Outcomes-based healthcare – an important opportunity for multidisciplinary care?
Patients to benefit from new proton beam therapy centres
UK cancer patients who need high-energy proton beam therapy treatment must often travel abroad to get it. Now, a new network of UK cancer centres will bring it closer to home.
Proton beam therapy treated Simon's cancer with few side effects
Simon Hardacre was the first cancer patient to receive high energy proton beam therapy here in the UK, a treatment that can treat some cancers with fewer side effects than conventional radiotherapy.
Why chemotherapy may not have been the answer for Adrienne
Adrienne had chemotherapy in 2005, but if she'd had access to a personalised treatment plan – her long-term health may have been significantly better.
Which women need chemotherapy?
Treatment options are becoming more personalised with the development of innovative genetic tests, which can tell a woman if she is at high or low risk of the cancer returning or spreading.
What is being done to improve survival for patients with cancer?
New drugs effectively un-mask hidden cancer cells, allowing their identification and destruction by the body’s immune system.
Tailor-made treatments for breast cancer
As worrying as the word ‘cancer’ may be, it is heartening to hear of medical innovations in the field. And breast cancer care has made striding advancements over the last 30 years.
What is gene therapy and how is it delivered?
New delivery vehicles can help to get gene therapies to the right place in the body, making these treatments more effective, at a lower cost and with less toxicity.
1948-2018: 70 years of oncology in the NHS
RCR Vice-President for Clinical Oncology Dr Jeanette Dickson shares her thoughts on the major developments in her speciality during the past 70 years and looks ahead to future advances as the national health service turns 70.
Three expert insights into the innovation in oncology in the UK
Progress in cancer research relies on collaboration, scientific talent and technological advances.
5 ways NHS Supply Chain is supporting innovation in radiotherapy
Tracy Bagnall, Senior Buyer for Radiotherapy at NHS Supply Chain, outlines 5 ways in which the company’s Radiotherapy Framework Agreement is structured to support market innovation and deliver savings to the NHS.
Radiotherapy reorganisation in the UK
Can cooperation triumph in the reorganisation of radiotherapy services in England?
National awareness of radiotherapy needed for patients
Radiotherapy has new and exciting innovations but there needs to be more public awareness of the benefits to patients.
Treating cancer with advanced proton therapy
Proton therapy is a rapidly expanding area with more than 50 centres in the world currently treating patients.
Stereotactic radiosurgery: a vital weapon to combat brain cancer
According to Mr Matthias Radatz, getting the right data is key to enabling doctors to make better decisions about the role of radiosurgery and treatment plan quality.
Working for the future: Therapeutic Radiographers
The health service may be struggling with a lack of radiographers, but the profession is responding to the challenges of the future with renewed focus.
Advancing the UK’s radiotherapy service
The complexity of radiotherapy continues to increase to improve treatment delivery and success. However, more work and resources are needed to ensure the UK provides a world-class radiotherapy service.
Cutting-edge technologies at the heart of the radiosurgery revolution
Big data, and the ability to personalise treatment plans, are shaping current developments in stereotactic radiosurgery.
Ensuring progress continues for multiple myeloma
Multiple myeloma is the second most common cancer of the bone marrow. Although there is no cure yet for this condition, survival has quadrupled since the 1970s. We need to ensure that progress continues.
Common drugs may help step up the fight against cancer
In January, a team led by Dr Pan Pantziarka, of the Anticancer Fund, Brussels, Belgium, published evidence suggesting that the widely used painkiller diclofenac may be useful for treating cancer.
How can we drive developments in myeloma research?
Eric Low explains why advancing myeloma treatment means working collaboratively and strategically and engaging early with downstream stakeholders.
Pulling together to beat cancer
We have come a long way, but we still have far to go before we reach a future free from the fear of cancer. That is what drives us on.
If we can see it, we can treat it
Every year, over two million women have breast screening in the UK, and 15,500 have their cancer detected through it. This saves an estimated 1,300 lives annually.
18-24 year olds more aware of cancer risks than over-55s
Cancer tends to be a disease of older people but a poll by the World Cancer Research Fund has revealed that those over 55 are less aware of four major cancer risk factors, compared to 18 to 24 year olds.
Brain tumours: the biggest cancer killer of children and young adults
Brain tumours kill more children and adults under the age of 40 than any other cancer.
Simple lifestyle changes to help keep cancer at bay
A recent survey for World Cancer Research Fund showed that more needs to be to be done to help people understand how they can reduce their cancer risk.
Pancreatic cancer patient story: Carl Denning
Carl Denning is an inspirational and positive man. He was diagnosed with pancreatic cancer in 2012 at the age of 38 and within weeks his whole life changed.
We are united against cancer
Cancer affects us all, regardless of our race, sex, geography or age. February 4
is the one day of the year where the world’s population can unite and take action against this ever increasing epidemic.
Teenage Cancer Trust case studies and key information
Teenage Cancer Trust has a unique partnership with the NHS. We work together to embed our vital services within theirs, complementing and significantly extending the care and support young people with cancer receive.
Breakthrough advances in cancer treatment and research
Innovative approaches to the management of cancer, from checkpoint inhibitors to liquid biopsies, are improving patient outcomes. We need to ensure that progress continues.
Better access to diagnostic tools and care is needed for pancreatic cancer
A report by the All-Party Parliamentary Group (APPG) on Pancreatic Cancer highlights that people with the illness don’t generally have timely access to diagnosis and care.
Why pancreatic cancer awareness is a priority
Difficult to diagnose and treat, pancreatic cancer has the lowest survival rate of all cancers and incredibly low research funding, says Ali Stunt, founder and CEO of Pancreatic Cancer Action.
We can beat pancreatic cancer
With only 3% of patients living five years with the condition, pancreatic cancer has the lowest survival rate of all cancers. What’s worse, the outlook for patients has remained unchanged for 40 years. But faster diagnoses and tests that increase access to clinical trials can turn things around.
Working together to make progress against cancer
Collaboration in research is key to building on the huge progress we’ve already made in treating cancer and to help bring new treatments to patients faster.
How we learned to live with cancer
ITV presenter and Bowel Cancer UK Patron Charlene White speaks on her family's ordeal with the disease and the importance of early detection.
Mesothelioma: emergency action is vital to tackle a public health disaster
At last action is being taken to speed up the search in treatments for mesothelioma, a fatal cancer caused by asbestos.
Experts call for better education of breast cancer amongst younger audiences
Despite the over 50s being most at risk of breast cancer, campaigners are seeing the benefit of reaching people earlier in life.
The UK delivers world’s first national pancreas tissue bank
In January 2016, after three years of painstaking discussions, deliberations and legal agreements, the Pancreatic Cancer Research Fund Tissue Bank launched, with the aim of accelerating research into the most lethal cancer.
Pioneering radiotherapy treatment benefits cancer patients
Around 50% of patients who are cured of their cancer receive radiotherapy, making this a gold standard treatment for a wide range of cancers, such as those of the prostate, breast, lung and head and neck.
Cancer prevention tips (World Cancer Research Fund)
Amy's cancer journey (Cancer Research UK)
Bones & Joints